High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paraganglioma
about
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes.Bortezomib Alone and in Combination With Salinosporamid A Induces Apoptosis and Promotes Pheochromocytoma Cell Death In Vitro and in Female Nude Mice.
P2860
High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paraganglioma
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
High-throughput screening for ...... chromocytoma and paraganglioma
@ast
High-throughput screening for ...... chromocytoma and paraganglioma
@en
High-throughput screening for ...... chromocytoma and paraganglioma
@nl
type
label
High-throughput screening for ...... chromocytoma and paraganglioma
@ast
High-throughput screening for ...... chromocytoma and paraganglioma
@en
High-throughput screening for ...... chromocytoma and paraganglioma
@nl
prefLabel
High-throughput screening for ...... chromocytoma and paraganglioma
@ast
High-throughput screening for ...... chromocytoma and paraganglioma
@en
High-throughput screening for ...... chromocytoma and paraganglioma
@nl
P2093
P2860
P1433
P1476
High-throughput screening for ...... chromocytoma and paraganglioma
@en
P2093
Abdel Elkahloun
Alessio Giubellino
Jane Trepel
Marc Ferrer
Min-Jung Lee
Nikita Patel
Petra Bullova
Uma Shankavaram
Yaqin Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0090458
P407
P577
2014-01-01T00:00:00Z